Is There Still a Glimmer of Hope for Sunedison Inc (SUNEQ)?
Sunedison Inc (OTCMKTS:SUNEQ) has been having an overwhelmingly hard time in market recently, and for a very good reason. Unfortunately, the company has …
Biotech Beat: Valeant Pharmaceuticals Intl Inc (VRX), Portola Pharmaceuticals Inc (PTLA)
By Terry Chrisomalis Valeant Pharmaceuticals Intl Inc On Monday March 21, 2016 shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) were halted pre-market before a …
Sunedison Inc (SUNE) From A Bullish Perspective
Sunedison Inc (NYSE:SUNE) is a company that has fallen on incredibly hard times. There’s no denying that.
Biotech Beat: MannKind Corporation (MNKD), Inovio Pharmaceuticals Inc (INO), Zafgen Inc (ZFGN)
MannKind Corporation On Thursday January 21, 2016 MannKind Corporation (NASDAQ:MNKD) had announced that it had entered into a license agreement, with a newly …
Unilife Corp (UNIS) Surges Following Agreement With Amgen, Inc. (AMGN)
Unilife Corp (NASDAQ: UNIS) is having an incredible day in the market today after disclosing an SEC filing with regard to an exclusivity agreement with Amgen, …
Bad News for GoPro Inc (GPRO) Stock
GoPro Inc (NASDAQ:GPRO) has been an incredibly interesting stock to follow as of late. Unfortunately, it’s not interesting in a positive way.
Nike Inc (NKE) Jumps After Earnings, But What Comes Next?
Nike Inc (NYSE:NKE) is having an incredible time in pre-market trading today after announcing earnings after the closing bell yesterday. Ultimately, earnings beat …
pSivida Corp. (PSDV) Stock: Climbing On Solid Data
pSivida Corp. (NASDAQ:PSDV) is having an incredible day in the market today after posting solid data from a recent Phase 3 clinical trial.
Biotech Stock News: Atara Biotherapeutics Inc (ATRA), Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN)
Atara Biotherapeutics Inc (NASDAQ:ATRA) On Monday December 14, 2015 shares of Atara Biotherapeutics tanked 37% after the company reported that a phase 2 …
AEterna Zentaris Inc. (USA): More Gains To Come
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) has had a rough year in the market.